Skip to content

Farnoush Abar, M.D.

NPI 1558560342ActiveIndividual· Internal Medicine, Hematology & Oncology· Seattle, WA

Internal Medicine, Hematology & Oncology (M.D.) in Seattle, Washington, licensed in WA, with an NPI issued in July 2007. Part D covered 674 prescriptions written in 2024, 77% of them generic. Myriad Genetic Laboratories, Inc. reported $20.35 in payments in 2024, mostly food and beverage.

Overview

NPI1558560342
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJul 12, 2007
Last updated in NPPESApr 19, 2024
Certified by providerApr 19, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Hematology & Oncology Primary207RH0003XMD61006345WA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (OR)

Part D prescriptions in 2024

Prescriptions (claims)674 · 882 30-day fills
Patients115
Total drug cost$1,711,831
Generic share77% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$20.35 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Myriad Genetic Laboratories, Inc.$20.351

What the 2024 payments were for

  • Food and Beverage$20.35 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Hematology & Oncology providers in Seattle

All Internal Medicine, Hematology & Oncology providers in Washington →